Nu-Med Plus (NUMD) Non-Current Deferred Tax Liability (2020 - 2022)
Nu-Med Plus (NUMD) reported Non-Current Deferred Tax Liability of $2267.0 for Q4 2022, down 76.47% on a YoY basis from $9635.0 in Q4 2021, and down 76.47% sequentially from $9635.0 in Q4 2021.
Nu-Med Plus (NUMD) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends
Nu-Med Plus (NUMD) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $2267.0 in Q4 2022.
- For the quarter ending Q4 2022, Non-Current Deferred Tax Liability fell 76.47% year-over-year to $2267.0; the trailing twelve-month figure through Dec 2022 stood at $2267.0 (down 76.47% YoY), and the FY2022 full-year result was $2267.0, down 76.47% from the prior year.
- Non-Current Deferred Tax Liability eased to $2267.0 in Q4 2022, from $9635.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11794.0 in Q4 2020 to a low of $2267.0 in Q4 2022.
- A 3-year average of $7898.7 and a median of $9635.0 in 2021 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability fell 18.31% in 2021 and slumped 76.47% in 2022, its largest moves.
- Tracing NUMD's Non-Current Deferred Tax Liability over 3 years: stood at $11794.0 in 2020, then slipped by 18.31% to $9635.0 in 2021, then tumbled by 76.47% to $2267.0 in 2022.
- Business Quant data shows NUMD's Non-Current Deferred Tax Liability at $2267.0 in Q4 2022, $9635.0 in Q4 2021, and $11794.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2,267.00 |
| Dec 31, 2022 | 2,267.00 |
| Dec 31, 2021 | 9,635.00 |
| Dec 31, 2021 | 9,635.00 |
| Dec 31, 2020 | 11,794.00 |
| Dec 31, 2020 | 11,794.00 |